Shares of The Clorox Company (NYSE:CLX - Get Free Report) have been given a consensus recommendation of "Reduce" by the seventeen analysts that are currently covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a sell recommendation and thirteen have given a hold recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $101.40.
Several equities research analysts recently issued reports on the stock. Weiss Ratings restated a "hold (c-)" rating on shares of Clorox in a report on Friday, July 10th. Jefferies Financial Group downgraded Clorox from a "buy" rating to a "hold" rating and lowered their target price for the company from $125.00 to $98.00 in a report on Tuesday, July 28th. UBS Group reissued a "neutral" rating on shares of Clorox in a research report on Friday, September 11th. JPMorgan Chase & Co. boosted their price target on Clorox from $92.00 to $95.00 and gave the company an "underweight" rating in a research note on Tuesday, August 4th. Finally, Wall Street Zen raised shares of Clorox from a "sell" rating to a "hold" rating in a research report on Saturday.
Check Out Our Latest Report on CLX
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new stake in shares of Clorox in the 2nd quarter worth $958,640,000. Geode Capital Management LLC lifted its position in Clorox by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company's stock valued at $318,613,000 after purchasing an additional 10,060 shares in the last quarter. Van ECK Associates Corp grew its holdings in Clorox by 15.7% during the fourth quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company's stock valued at $316,244,000 after purchasing an additional 426,433 shares during the period. Bank of America Corp DE bought a new stake in Clorox during the second quarter valued at about $179,780,000. Finally, Arrowstreet Capital Limited Partnership increased its position in Clorox by 9.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,619,396 shares of the company's stock worth $163,284,000 after buying an additional 142,463 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.
Clorox Trading Down 2.1%
Clorox stock opened at $83.17 on Friday. Clorox has a one year low of $83.09 and a one year high of $128.90. The business's fifty day moving average is $98.27 and its 200 day moving average is $99.13. The stock has a market capitalization of $10.06 billion, a PE ratio of 17.26, a price-to-earnings-growth ratio of 2.66 and a beta of 0.56. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38.
Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.02. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.Clorox's revenue was down 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, sell-side analysts predict that Clorox will post 5.8 EPS for the current year.
Clorox Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 28th. Investors of record on Wednesday, August 12th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 6.0%. This is a positive change from Clorox's previous quarterly dividend of $1.24. The ex-dividend date was Wednesday, August 12th. Clorox's dividend payout ratio (DPR) is presently 103.73%.
Clorox Company Profile
(
Get Free Report)
The Clorox Company NYSE: CLX is a consumer products company that develops, manufactures and markets household, health and wellness, and lifestyle products. Its portfolio includes cleaning and disinfecting products, laundry and home-care items, food products, personal-care products, water-filtration systems, charcoal, and cat litter.
Clorox's brands include Clorox bleach and disinfecting products, Pine-Sol, Fresh Step and Scoop Away, Kingsford, Brita, Burt's Bees, Hidden Valley, and products marketed under the Glad name.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.